Alexander Belavin

Source: Wikipedia, the free encyclopedia.

Alexander "Sasha" Abramovich Belavin (Russian: Алекса́ндр Абра́мович Бела́вин, born 1942)[1] is a Russian physicist, known for his contributions to string theory.

He is a professor at the Independent University of Moscow and а researcher at the Landau Institute for Theoretical Physics. He is also a member of the editorial board of the Moscow Mathematical Journal.

Work

Belavin participated in the discovery of the BPST instanton (1975) which aided the understanding of the chiral anomaly and gave new directions within quantum field theory. With G. Avdeeva he showed evidence of new coupling regimes for gauge field theory (1973). He also developed the Belavin S-matrices, exactly solvable models in two-dimensional relativistic theories (1981). He co-authored the BPZ paper (1984) with Alexander Polyakov and Alexander Zamolodchikov on two-dimensional conformal field theory, which became important for string theory. With Vadim Knizhnik he obtained the Belavin–Knizhnik theorem on dual amplitudes in string theory (1986).

Awards

Political positions

In February 2022, he signed an open letter by Russian scientists condemning the 2022 Russian invasion of Ukraine.[3]

Publications

  • Belavin AA; Polyakov AM; Zamolodchikov AB (1984). "Infinite conformal symmetry in two-dimensional quantum field theory". Nucl. Phys. B. 241 (2): 333–80. Bibcode:1984NuPhB.241..333B. doi:10.1016/0550-3213(84)90052-X.
  • Belavin, A.; Pugai, Y.; Zamolodchikov, A. (2012). Quantum Field Theories in Two Dimensions: Collected Works of Alexei Zamolodchikov. World Scientific. ISBN 978-981-4324-06-9.

See also

References

  1. ^ "Belavin, A. A. (Aleksandr A.), 1942-" (entry in the Library of Congress)
  2. ^ Pomeranchuk winners 2007 Archived 2011-07-22 at the Wayback Machine
  3. ^ "Открытое письмо российских учёных и научных журналистов против войны с Украиной" [An open letter from Russian scientists and scientific journalist against the war in Ukraine] (in Russian). 24 February 2022. Retrieved 2 April 2022.